Gold Daniel Allen 4

What Happened

• Director Gold Daniel Allen reported multiple open-market sales of Roivant Sciences (ROIV) shares totaling 1,225,784 shares for aggregate proceeds of $32,658,518 (average ≈ $26.64/share). The sales occurred across Feb 11–13, 2026 and are reported as dispositions (transaction code S).

Key Details

• Dates and prices:
  • 2026-02-11: 425,000 shares @ $26.67 — $11,334,750
  • 2026-02-12: 150,000 shares @ $26.72 — $4,008,000
  • 2026-02-12: 275,000 shares @ $26.76 — $7,359,000
  • 2026-02-13: 150,784 shares @ $26.49 — $3,994,268
  • 2026-02-13: 225,000 shares @ $26.50 — $5,962,500
• Total sold: 1,225,784 shares for $32,658,518 (avg ≈ $26.64/share).
• Shares owned after transaction: not specified in the filing.
• Footnote: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. (QVT FIC) and shares voting/investment control over the shares held directly by QVT FIC; he disclaims beneficial ownership except to the extent of any pecuniary interest.
• Filing timeliness: Form 4 filed Feb 13, 2026; no late filing flag noted.

Context

• These were sales (dispositions), not purchases or option exercises. Sales by institutional-affiliated reporting persons can reflect portfolio rebalancing or liquidity needs and are not, by themselves, a definitive signal about company outlook.
• The footnote indicates these shares were held through an investment vehicle (QVT FIC), so this report reflects institutional-related trading rather than necessarily personal insider trading.